ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,633,000 | -56.6% | 157,000 | -56.0% | 0.83% | -34.1% |
| Q4 2019 | $15,272,000 | +371.5% | 357,000 | +296.7% | 1.26% | +151.8% |
| Q3 2019 | $3,239,000 | -36.7% | 90,000 | -47.1% | 0.50% | -16.8% |
| Q4 2017 | $5,119,000 | +28.7% | 170,000 | +36.0% | 0.60% | -7.1% |
| Q3 2016 | $3,976,000 | -5.2% | 125,000 | -16.7% | 0.65% | -28.8% |
| Q1 2016 | $4,194,000 | +17.6% | 150,000 | +50.0% | 0.91% | +74.1% |
| Q4 2015 | $3,565,000 | – | 100,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |